Back to Products
Tablet
MONEAST-FX
Fexofenadine Hydrochloride (120 mg), Montelukast (10 mg)
Empower your clinical outcomes with MONEAST-FX, containing Fexofenadine Hydrochloride (120 mg), Montelukast (10 mg), manufactured under strict WHO-GMP compliance by Ramitra Biotech in 10 x 10 Aluminium packing to ensure maximum purity and bioavailability.
📋 Specifications
| Product Name | MONEAST-FX |
|---|---|
| Composition | Fexofenadine Hydrochloride (120 mg), Montelukast (10 mg) |
| Category | Tablet |
| Packaging | 10 x 10 Aluminium |
| Certifications | WHO-GMP Certified / ISO 9001:2015 Approved |
| Franchise Availability | Available for PCD Franchise |
Product Indications & Details
MONEAST-FX Tablets feature an advanced combination of Fexofenadine Hydrochloride 120 mg and Montelukast 10 mg for comprehensive allergy relief.
Conveniently supplied in a high-quality 10 x 10 aluminium-aluminium packaging designed to preserve drug potency and ensure optimal stability.
Fexofenadine Hydrochloride provides fast-acting non-drowsy antihistamine relief from common symptoms such as sneezing, runny nose, and watery eyes.
Montelukast functions as a potent leukotriene receptor antagonist that reduces airway inflammation and controls allergic respiratory symptoms.
Specially formulated by Ramitra Biotech to offer effective 24-hour management of seasonal and perennial allergic rhinitis.
Manufactured under strict quality assurance standards to guarantee clinical safety, consistency, and high patient compliance.
Quantity
![YORKREST-DS [ANTICOLD SYP]](/_next/image?url=https%3A%2F%2Fres.cloudinary.com%2Fdjnazrjqf%2Fimage%2Fupload%2Fv1784990132%2Frami%2Fimages%2Fproducts%2Fyorkrest-ds--anticold-syp-%2F001.png&w=3840&q=75)